The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 7, Pages 1723
Publisher
MDPI AG
Online
2020-06-30
DOI
10.3390/cancers12071723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastatic Renal Cell Carcinoma to the Brain
- (2019) Wei Zheng et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma
- (2019) Prashant Mujumdar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Hypoxia Downstream Signaling Protein, CAIX, for CAR-T Cell Therapy against Glioblastoma
- (2019) Jing Cui et al. NEURO-ONCOLOGY
- Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor
- (2019) Ricarda Hannen et al. Cancers
- Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance
- (2019) Ana Podolski-Renić et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms
- (2019) Mohammed Albatany et al. JOURNAL OF NEURO-ONCOLOGY
- Carbonic anhydrase IX and acid transport in cancer
- (2019) Holger M. Becker BRITISH JOURNAL OF CANCER
- Evaluating off-label uses of acetazolamide
- (2018) Megan A. Van Berkel et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ
- (2018) Xiaoshan Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
- (2018) Bulent Cetin et al. NEUROPATHOLOGY
- BCL3 expression promotes resistance to alkylating chemotherapy in gliomas
- (2018) Longtao Wu et al. Science Translational Medicine
- Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma
- (2018) Iris C. Salaroglio et al. MOLECULAR CANCER THERAPEUTICS
- Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
- (2017) Jyotsna U. Rao et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Inhibition of carbonic anhydrase IX in glioblastoma multiforme
- (2016) Abdolali Amiri et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Topiramate induces acute intracellular acidification in glioblastoma
- (2016) Kamini Marathe et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- (2016) Simon J. A. van Kuijk et al. Frontiers in Oncology
- Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)
- (2015) S S Islam et al. Targeted Oncology
- CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
- (2015) Richard E. Kast et al. Oncotarget
- Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including Acetazolamide in human Glioblastoma
- (2013) Harun M. Said et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines
- (2013) Reza Bayat Mokhtari et al. BMC CANCER
- Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review
- (2013) Mayank Aggarwal et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- An update on carbonic anhydrase-related proteins VIII, X and XI
- (2013) Ashok Aspatwar et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system
- (2012) Shirley Abraham et al. JOURNAL OF NEURO-ONCOLOGY
- NMDA Receptor-Dependent Afterdepolarizations Are Curtailed by Carbonic Anhydrase 14: Regulation of a Short-Term Postsynaptic Potentiation
- (2012) S. Makani et al. JOURNAL OF NEUROSCIENCE
- Function of carbonic anhydrase IX in glioblastoma multiforme
- (2012) M. A. Proescholdt et al. NEURO-ONCOLOGY
- Predicting Outcomes of Patients With Intracranial Meningiomas Using Molecular Markers of Hypoxia, Vascularity, and Proliferation
- (2012) Randy Jensen et al. NEUROSURGERY
- Hypoxia-related molecules HIF-1α, CA9, and osteopontin
- (2012) O.P. Erpolat et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
- (2011) A M Jubb et al. BRITISH JOURNAL OF CANCER
- Expression of carbonic anhydrase IX in craniopharyngiomas
- (2011) Martin Proescholdt et al. JOURNAL OF NEUROSURGERY
- Brain phenotype of carbonic anhydrase IX-deficient mice
- (2011) Pei-wen Pan et al. TRANSGENIC RESEARCH
- The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis
- (2010) Kristiina Nordfors et al. BMC CANCER
- The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis
- (2010) Lee INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors
- (2010) Seppo Parkkila et al. MODERN PATHOLOGY
- Clear Cell Meningioma: A Clinicopathologic Study of 18 Tumors and Examination of the Use of CD10, CA9, and RCC Antibodies to Distinguish Between Clear Cell Meningioma and Metastatic Clear Cell Renal Cell Carcinoma
- (2010) Richard A. Prayson et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
- (2009) M. Maschio et al. JOURNAL OF NEURO-ONCOLOGY
- Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features
- (2009) Katariina Korhonen et al. JOURNAL OF NEUROSURGERY
- Significance of pH regulation and carbonic anhydrases in tumour progression and implications for diagnostic and therapeutic approaches
- (2008) Seppo Parkkila BJU INTERNATIONAL
- Carbonic anhydrase IX in oligodendroglial brain tumors
- (2008) Sally Järvelä et al. BMC CANCER
- Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme
- (2008) Jeannette R. Flynn et al. CANCER
- Recent Advances in Research on the Most Novel Carbonic Anhydrases,CA XIII and XV
- (2008) S. Parkkila et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer-Associated Carbonic Anhydrases and Their Inhibition
- (2008) J. Pastorek et al. CURRENT PHARMACEUTICAL DESIGN
- Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
- (2008) Sith Sathornsumetee et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas
- (2008) Joonas Haapasalo et al. NEURO-ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started